Welcome

New bill will require disclosure of drug company payments to doctors

May 9th, 2012

The Physician Payment Sunshine Act—part of the 2010 health care overhaul—will require drug companies to disclose when and how much they pay physicians to give talks or conduct research. The provision will attempt to prevent bias in research and presentations paid for by drug companies, such as the case in which a Paxil researcher overlooked reports of suicidal tendencies by… read more »

Antidepressants during pregnancy increases high blood pressure risk

April 12th, 2012

A new study published by the British Journal of Clinical Pharmacology has found that women taking antidepressants while pregnant are more likely to develop high blood pressure than non-users. Pregnant women who used Paxil were 81% more likely to develop high blood pressure, while users of Zoloft and other antidepressants were 51% more likely to develop the condition.… read more »

FDA issues Celexa heart disease warning

March 29th, 2012

The Food and Drug Administration has issued a Celexa warning about the risk of a rare heart condition among patients who take the antidepressant drug. The agency said that it plans to add a new label warning that Celexa can increase the risk of QT syndrome—a rare heart disease that causes problems with the heart’s electrical activity.… read more »

Paxil linked to pregnancy complication risk

March 23rd, 2012

A recent study has found that children born to mothers using antidepressants such as Paxil had slower head development and were more likely to be born prematurely. The study—conducted in The Netherlands and from date involving nearly 8,000 pregnant women—focused on the effects of a type of antidepressants known as selective serotonin reuptake inhibitors (SSRIs), which includes Paxil.… read more »

Paxil during third trimester triples risk of serious birth defect, study finds

February 15th, 2012

A recent study published in the British Medical Journal (BMJ) has found that women who use the antidepressant drug Paxil during the third trimester of pregnancy are nearly three times more likely than non-users to give birth to a child with persistent pulmonary hypertension of the newborn (PPHN).… read more »

Page 1 of 712345...Last »

Contact Us Today for a Free Consultation.

PaxilZoloftProzacWellbutrinCelexaLexaproEffexorXanaxOtherNone
YesNo
I am currently represented by an attorney.
Required:
*Required fields